These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 24048686)
1. The evolving spectrum of polymyositis and dermatomyositis--moving towards clinicoserological syndromes: a critical review. Tansley S; Gunawardena H Clin Rev Allergy Immunol; 2014 Dec; 47(3):264-73. PubMed ID: 24048686 [TBL] [Abstract][Full Text] [Related]
2. [Myositis-specific autoantibodies and their clinical significance]. Suzuki S Brain Nerve; 2011 Nov; 63(11):1197-203. PubMed ID: 22068472 [TBL] [Abstract][Full Text] [Related]
3. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Gunawardena H; Betteridge ZE; McHugh NJ Rheumatology (Oxford); 2009 Jun; 48(6):607-12. PubMed ID: 19439503 [TBL] [Abstract][Full Text] [Related]
4. Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis/dermatomyositis and related conditions. Hirakata M Nihon Rinsho Meneki Gakkai Kaishi; 2007 Dec; 30(6):444-54. PubMed ID: 18174673 [TBL] [Abstract][Full Text] [Related]
5. [Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases]. Xie MM; Zou RY; Li Y; Liu Y; Chen LL; Liu XQ; Zhao Q; Ding JJ; Chen ZY; Cai HR Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):765-770. PubMed ID: 31594111 [No Abstract] [Full Text] [Related]
6. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis. Srivastava P; Dwivedi S; Misra R Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471 [TBL] [Abstract][Full Text] [Related]
7. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis. Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751 [TBL] [Abstract][Full Text] [Related]
8. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies. Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871 [TBL] [Abstract][Full Text] [Related]
9. The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies. Li S; Ge Y; Yang H; Wang T; Zheng X; Peng Q; Lu X; Wang G Clin Rheumatol; 2019 Aug; 38(8):2171-2179. PubMed ID: 30863950 [TBL] [Abstract][Full Text] [Related]
10. Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort. Tarricone E; Ghirardello A; Rampudda M; Bassi N; Punzi L; Doria A J Immunol Methods; 2012 Oct; 384(1-2):128-34. PubMed ID: 22884621 [TBL] [Abstract][Full Text] [Related]
11. Autoantibodies in polymyositis and dermatomyositis. Ghirardello A; Bassi N; Palma L; Borella E; Domeneghetti M; Punzi L; Doria A Curr Rheumatol Rep; 2013 Jun; 15(6):335. PubMed ID: 23591825 [TBL] [Abstract][Full Text] [Related]
12. Immunoserological aspects of idiopathic inflammatory muscle disease. Rozman B; Bozic B; Kos-Golja M; Plesivcnik-Novljan M; Kveder T Wien Klin Wochenschr; 2000 Aug; 112(15-16):722-7. PubMed ID: 11020964 [TBL] [Abstract][Full Text] [Related]
13. Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis. Yeker RM; Pinal-Fernandez I; Kishi T; Pak K; Targoff IN; Miller FW; Rider LG; Mammen AL; Ann Rheum Dis; 2018 May; 77(5):714-719. PubMed ID: 29363513 [TBL] [Abstract][Full Text] [Related]
14. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets. Merlo G; Clapasson A; Cozzani E; Sanna L; Pesce G; Bagnasco M; Burlando M; Parodi A Arch Dermatol Res; 2017 Mar; 309(2):87-95. PubMed ID: 27928683 [TBL] [Abstract][Full Text] [Related]
15. [Autoantibodies specifically detected in patients with polymyositis/dermatomyositis]. Sato S Nihon Rinsho Meneki Gakkai Kaishi; 2006 Apr; 29(2):85-93. PubMed ID: 16651706 [TBL] [Abstract][Full Text] [Related]
16. Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis. Mammen AL Ann N Y Acad Sci; 2010 Jan; 1184():134-53. PubMed ID: 20146695 [TBL] [Abstract][Full Text] [Related]
17. Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy. Venalis P; Lundberg IE Rheumatology (Oxford); 2014 Mar; 53(3):397-405. PubMed ID: 23970542 [TBL] [Abstract][Full Text] [Related]
18. Autoantibody to transcriptional intermediary factor-1β as a myositis-specific antibody: clinical correlation with clinically amyopathic dermatomyositis or dermatomyositis with mild myopathy. Ueda-Hayakawa I; Hamaguchi Y; Okiyama N; Motegi S; Yamaoka T; Miyake S; Higashi A; Okamoto H; Takehara K; Fujimoto M Br J Dermatol; 2019 Apr; 180(4):881-887. PubMed ID: 30120913 [TBL] [Abstract][Full Text] [Related]
19. Autoantibodies in adult patients with idiopathic inflammatory myopathies in Buenos Aires. Gómez GN; Gargiulo Mde L; Pérez N; Collado MV; Suárez LV; Khoury M; Sarano JF Medicina (B Aires); 2016; 76(3):129-34. PubMed ID: 27295700 [TBL] [Abstract][Full Text] [Related]
20. [New insights of myositis-specific and -associated autoantibodies in juvenile and adult type myositis]. Váncsa A; Dankó K Orv Hetil; 2016 Jul; 157(30):1179-84. PubMed ID: 27452067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]